User:Okla201919/sandbox

John Chiminski is an American engineer and business executive. Chiminski led the development of the world's first multislice computed tomography scanner GE Lightspeed. From 2007 to 2009 he was President and CEO of General Electric Medical Diagnostics after serving in various engineering, operations and management roles in GE Healthcare for over 20 years. He became the CEO of the pharmaceutical manufacturer Catalent in March 2009 and led it to become a publicly traded company in July 2014.

In June 2020, Chiminski announced a deal to manufacture at least 100 million doses of Moderna COVID19 vaccine. As of December 2020, Catalent has been producing a 500,0000 doses of the vaccine at its biologics facility in Bloomington, Indiana.

Early Life and Education
John Chiminski grew up near Detroit, MI where his father Walter worked in the manufacturing industry as a skilled tradesman. John Chiminski received a BS in Electrical Engineering from Michigan State University in 1986. He then completed an M.S. from Purdue University School of Electrical and Computer Engineering in 1987 specializing in automatic control with Stanislaw H. Żak as an advisor. Chiminski also received an MBA from the Kellogg School of Management at Northwestern University in 1996.

Awards and Recognition
Chiminski received an outstanding alumnus award from Purdue University School of Electrical and Computer Engineering in 2006 and was named a Distinguished Engineering Alumnus by Purdue University College of Engineering in 2012.

In 2019 he was selected as the inaugural recipient of CPhl Pharma Lifetime Achievement Award.